100 things to watch in 2011: JWT

JWT
Grey India has bagged the mandate in place of GlaxoSmithKline Consumer Healthcare's (GSKCH) foray into the oral custody segment with Sensodyne Toothpaste. GSK is planning to invest close to Rs 25 crore in place of the launch part of Sensodyne.
The agency is working on the multimedia campaign which will function on-air nationally in last-minute January. For the pick up, Grey India has been use GSKCH's nasal custody artifact Breathe Right since its launch.
Commenting on the launch of the brand in India, Shubhajit Sen, executive junior president - marketing, GlaxoSmithKline Consumer Healthcare, India, thought, “GSKCH has every time endeavored to develop another products catering to the constantly changing needs of its consumers. It strives to provide them with products with the aim of help them live a better life.  Tooth sensitivity is a growing occurrence amongst Indians, but unfortunately the awareness and solution around the circulation continues to be low. Sensodyne is a consumer preferred and expert legitimate brand globally and we are excited to bring the remuneration of this artifact to Indian consumers.”
On the campaign scheduled in place of the brand, Ketan Desai, companion VP and branch head, Grey Delhi, thought, "The campaign will be based on the insight of creating awareness to a condition someplace single feels a small hard hurt in their teeth on consumption of no matter which very scorching or cold, and the availability of a artifact in place of curing the same." 
The nationwide launch of Sensodyne was preceded by test marketing in South India. The marketing campaign concerning activations upper-class 'Chill Test', will create awareness on the of great consequence circulation of sensitivity amongst consumers and allot them a ability to contract themselves tested in place of dental sensitivity. The marketing diagram besides includes an extensive outreach to Dentists and Dental Colleges to create advocates in place of the brand.